Which dye gives sharper brain pictures? new study compares two MRI contrast agents
NCT ID NCT06846853
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two FDA-approved contrast agents, Gadopiclenol and Gadobutrol, to see which one makes pituitary lesions clearer on MRI scans. Ten adults with known or suspected pituitary lesions will each receive both agents in random order, and neither they nor the researchers will know which is being used. The goal is to improve image quality for diagnosing pituitary conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRAST ENHANCED IMAGES VS. NON-CONTRAST IMAGES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Connecticut Health Center
RECRUITINGFarmington, Connecticut, 06030, United States